moxifloxacin has been researched along with azd0914 in 1 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (azd0914) | Trials (azd0914) | Recent Studies (post-2010) (azd0914) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 33 | 8 | 33 |
| Protein | Taxonomy | moxifloxacin (IC50) | azd0914 (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 4.3 | |
| DNA gyrase subunit A | Staphylococcus aureus | 4.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basarab, GS; Byl, JAW; Chibale, K; Engelhart, C; Eyermann, CJ; Fienberg, S; Ghorpade, SR; Govender, P; Koekemoer, L; Meshanni, J; Müller, R; Myrick, A; Osheroff, N; Reddy, V; Schnappinger, D; Singh, K; Singh, V | 1 |
1 other study(ies) available for moxifloxacin and azd0914
| Article | Year |
|---|---|
Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA Gyrase; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Topoisomerase II Inhibitors | 2022 |